| Income Statement | 2025-09-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 50 | 104 | 32 | |
| Cost of revenue | 103 | 306 | 160 | |
| Gross loss | -53 | -202 | -128 | |
| Research and development | 3,061 | 3,767 | 3,838 | |
| Sales and marketing | 631 | 74 | 67 | |
| General and administrative | 4,080 | 3,803 | 4,223 | |
| Total operating expenses | 7,772 | 7,644 | 8,128 | |
| Loss from operations | -7,825 | -7,846 | -8,256 | |
| Change in fair value of convertible note and warrant liabilities | -2,210 | 9 | -15 | |
| Interest income and other | 650 | 233 | 228 | |
| Interest expense and other | -55 | 1,102 | -56 | |
| Total other income (expense), net | -1,505 | -860 | 269 | |
| Loss before income tax-Prototype Sales | -9,330 | - | - | |
| Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest | - | -8,706 | -7,987 | |
| Provision for income tax-Development Contracts | 0 | - | - | |
| Net loss | -9,330 | -8,706 | -7,987 | |
| Change in net unrealized gain (loss) on available-for-sale securities, net of tax | -4 | 35 | -4 | |
| Comprehensive loss | -9,334 | -8,671 | -7,991 | |
| Net loss per common share (basic and diluted) (in dollars per share) | -0.3 | -1.01 | -1.16 | |
| Weighted average common shares outstanding (basic and diluted) (in shares) | 31,262,997 | 8,629,683 | 6,874,454 | |
| Weighted average common shares outstanding - diluted (in shares) | 31,262,997 | 8,629,683 | 6,874,454 | |
AEye, Inc. (LIDR)
AEye, Inc. (LIDR)